← Evidence map

ArticlemedRxiv : the preprint server for health sciences2025

Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals with Type 1 Diabetes.

Elizabeth R Flammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41480032